<?xml version="1.0" encoding="UTF-8"?>
<urlset
      xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
      xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9
            http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
<url>
  <loc>https://www.ketabon.health/</loc>
  <lastmod>2023-01-18T10:03:17+00:00</lastmod>
  <priority>1.00</priority>
</url>
<url>
  <loc>https://www.ketabon.health/+4915123146187</loc>
  <lastmod>2023-01-18T10:03:17+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ketabon.health/legal-notice</loc>
  <lastmod>2023-01-18T10:03:17+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ketabon.health/pdf/Ketabon_Company_Presentation.pdf</loc>
  <lastmod>2022-12-23T11:38:36+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ketabon.health/news/First-patient-dosed-in-second-Phase-2-Add-on</loc>
  <lastmod>2023-01-18T10:03:17+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ketabon.health/news/Promising-preliminary-Results-in-TRD</loc>
  <lastmod>2023-01-18T10:03:17+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ketabon.health/news/Phase-2-Proof-of-Concept</loc>
  <lastmod>2023-01-18T10:03:17+00:00</lastmod>
  <priority>0.80</priority>
</url>
<url>
  <loc>https://www.ketabon.health/privacy-policy</loc>
  <lastmod>2023-01-18T10:03:17+00:00</lastmod>
  <priority>0.80</priority>
</url>


</urlset>